Limited/JJ
proteolysis/NN
for/IN
assaying/VBG
ligand/NN
binding/NN
affinities/NNS
of/IN
nuclear/JJ
receptors/NNS
./.

The/DT
binding/NN
of/IN
natural/JJ
or/CC
synthetic/JJ
ligands/NNS
to/TO
nuclear/JJ
receptors/NNS
is/VBZ
the/DT
triggering/VBG
event/NN
leading/VBG
to/TO
gene/NN
transcription/NN
activation/NN
or/CC
repression/NN
./.
=====
Ligand/NN
binding/VBG
to/TO
the/DT
ligand/NN
binding/NN
domain/NN
of/IN
these/DT
receptors/NNS
induces/VBZ
conformational/JJ
changes/NNS
that/WDT
are/VBP
evidenced/VBN
by/IN
an/DT
increased/VBN
resistance/NN
of/IN
this/DT
domain/NN
to/TO
proteases/NNS
./.
=====
In/FW
vitro/FW
labeled/VBN
receptors/NNS
were/VBD
incubated/VBN
with/IN
various/JJ
synthetic/JJ
or/CC
natural/JJ
agonists/NNS
or/CC
antagonists/NNS
and/CC
submitted/VBN
to/TO
trypsin/NN
digestion/NN
./.
=====
Proteolysis/NN
products/NNS
were/VBD
separated/VBN
by/IN
SDS-PAGE/NN
and/CC
quantified/VBN
./.
=====
The/DT
amount/NN
of/IN
trypsin-resistant/JJ
fragments/NNS
was/VBD
proportional/JJ
to/TO
receptor/NN
occupancy/NN
by/IN
the/DT
ligand/NN
,/,
and/CC
allowed/VBD
the/DT
determination/NN
of/IN
dissociation/NN
constants/NNS
(/(
kDa/NN
)/)
./.
=====
Using/VBG
the/DT
wild-type/JJ
or/CC
mutated/VBN
human/JJ
retinoic/JJ
acid/NN
receptor/NN
alpha/NN
as/IN
a/DT
model/NN
,/,
kDa/NN
values/NNS
determined/VBN
by/IN
classical/JJ
competition/NN
binding/NN
assays/NNS
using/VBG
tritiated/JJ
ligands/NNS
are/VBP
in/IN
agreement/NN
with/IN
those/DT
measured/VBN
by/IN
the/DT
proteolytic/JJ
assay/NN
./.
=====
This/DT
method/NN
was/VBD
successfully/RB
extended/VBN
to/TO
human/JJ
retinoic/JJ
X/NN
receptor/NN
alpha/NN
,/,
glucocorticoid/NN
receptor/NN
,/,
and/CC
progesterone/NN
receptor/NN
,/,
thus/RB
providing/VBG
a/DT
basis/NN
for/IN
a/DT
new/JJ
,/,
faster/JJR
assay/NN
to/TO
determine/VB
simultaneously/RB
the/DT
affinity/NN
and/CC
conformation/NN
of/IN
receptors/NNS
when/WRB
bound/VBN
to/TO
a/DT
given/JJ
ligand/NN
./.